An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Drug Acquiring Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before directing customers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Express Worries
However, physicians and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals injecting products of uncertain source.
Some professionals said the popularity for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.
Service Reaction and Content Elimination
According to the social media company, the service has removed problematic content and banned associated hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and investing in strengthening compliance measures.
Online Trading Operations
Investigations also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.
Within minutes of joining one group, a vendor posted contact information, where most transactions occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.
Item Information and Costs
Within these groups, messages display dark colored parcels with postal service labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered patients injured by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly significant medical dangers”.
